Home / Archive / April 2008

April 2008 Volume 4, Issue 4

Volume 4, Issue 4 | April 2008

In this Issue

Global News

Teva: Hola, Bentley

$360M acquisition will allow Teva to capture Bentley’s market share in Spain

Small, but mighty

Alimera, pSivida bolster plan to bring DME eye implant to market

Takeda joins HRP Initiative’s fight against high-risk plaque disease

Japanese pharmaceutical research company Takeda Pharmaceutical Co. Ltd. has joined BG Medicine, Merck, AstraZeneca and Philips as the newest member of the High-Risk Plaque (HRP) Initiative, a pre-competitive industry collaboration working to reduce morbidity, mortality and costs associated with cardiovascular disease.

CBI forms outsourcing services joint venture with Venturepharm

With plans to offer a comprehensive suite of outsourcing services to the global pharmaceutical industry, Commonwealth Biotechnologies Inc. (CBI), a provider of research and development products and services to the life sciences industry, has formed a joint venture with Venturepharm Laboratories Ltd. (VPL), a publicly-listed pharmaceutical research service company in Beijing, China.

Editor's Focus

Of baseball and a cognitively-enhanced editor

I’m not ashamed to say that in the last hour I pumped roughly 200 mg of my favorite drug into my body in an attempt to be ready, focused and able to produce an editorial that is, if not entertaining, at least cogent.

Automation & Instrumentation

RAPid move for discovery

TTP LabTech gains license to Resonant Acoustic Profiling from Cambridge Medical Innovations

Astech “REACTS” to market

Company hopes to leverage its new automation maintenance service to gain new customers

Genomes for $100?

Battelle Ventures, BioNanomatrix hope to slash genome costs

SmartSlide slips into six foreign markets

Hoping to set a new standard in cell culture study, WaferGen Biosystems Inc. announced six distributor agreements in as many weeks for the company’s SmartSlide Micro-Incubation System, a first-of-its kind family of integrated fluidics exchange micro-incubation products.

Getting with the flow

Millipore, Guava team up to create new flow cytometry solutions for the cell biology market

Genomics & Proteomics

Putting the brakes on cancer?

Yale, Asuragen scientists show miRNA can reduce lung cancer growth

Some Texas teamwork

Houston company signs proteomic tech agreement with MD Anderson

Extending half-lives, cutting costs for proteins

Novozymes licenses albufuse technology to CSL Behring for therapeutic protein work

Probing the Parsi people

AVESTAGENOME Project to study genetic causes of Parsi longevity

Silence's siRNA is golden

Silence Therapeutics and AstraZeneca strike new deal to design ways of delivering siRNA therapeutics

Research & Development

Critical path thinking

Immune Tolerance Institute, in collaboration with Beckman Coulter, establishes the Center for Critical Path Immunology

Kantor appointed chief scientific officer for ITI

Earlier this month, the Immune Tolerance Institute Inc. (ITI) announced that Aaron B. Kantor, Ph.D. has joined the company in the position of chief scientific officer, reporting to Louis A. Matis, M.D., president and CEO.

Lilly, Transition to tackle diabetes

Companies to explore gastrin-based therapies to regenerate insulin-producing cells

Lilly taps Suven for CNS research

Collaboration to broaden preclinical research of CNS molecules

BioInvent and Bayer seal therapeutic antibody deal

BioInvent International AB in March struck a deal with Bayer HealthCare related to the discovery and development of antibody products under which Bayer will have a non-exclusive research license for the use of BioInvent’s proprietary n-CoDeR library for the discovery of human monoclonal antibodies.

Next gen stem cell research

VistaGen, McEwen Centre to advance embryonic stem cell technologies

Informatics

Capturing the EDC market

Bio-Imaging Technologies acquires Phoenix Data Systems for $24 million

75 different translations

RemedyMD, GulfSream Bioinformatics merge software for translational research solutions

From co-marketing to embedded partners

Agilent, Accelrys take partnership to the next level

Quantum leap ahead

QuantumBio Inc. recently netted a FastTrack Small Business Innovation Research Grant (SBIR) of more than $865,000 from the NIH for research and development of novel, quantum mechanics-based methodologies for protein/drug scoring and interaction decomposition to help better understand protein-drug interactions.

April 2008